| 1 |
Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
DOI
ScienceOn
|
| 2 |
Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639-46.
DOI
ScienceOn
|
| 3 |
Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867-76.
DOI
ScienceOn
|
| 4 |
Towbin JA, Bowles NE. The failing heart. Nature 2002;415:227-33.
DOI
ScienceOn
|
| 5 |
Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001; 104:557-67.
DOI
ScienceOn
|
| 6 |
Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 2008;5:158-68.
DOI
ScienceOn
|
| 7 |
Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
|
| 8 |
Semsarian C; CSANZ Cardiac Genetics Diseases Council Writing Group. Guidelines for the diagnosis and management of hypertrophic cardiomyopathy. Heart Lung Circ 2011;20:688-90.
DOI
ScienceOn
|
| 9 |
Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005;96:270-5.
DOI
ScienceOn
|
| 10 |
Maron BJ, McKenna WJ, Elliott P, Spirito P, Frenneaux MP, Keren A, et al. Hypertrophic cardiomyopathy. JAMA 1999;282:2302-3.
DOI
ScienceOn
|
| 11 |
Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 2010;6:401-13.
DOI
ScienceOn
|
| 12 |
Bilgic A, Ozbarlas N, Ozkutlu S, Ozer S, Ozme S. Cardiomyopathies in children. Clinical, epidemiological and prognostic evaluation. Jpn Heart J 1990;31:789-97.
DOI
|
| 13 |
Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol 1997;146:385-93.
DOI
ScienceOn
|
| 14 |
Oh JH, Hong YM, Choi JY, Kim SJ, Jung JW, Sohn S, et al. Idiopathic cardiomyopathies in Korean children: 9-year Korean multicenter study. Circ J 2011;75:2228-34.
DOI
ScienceOn
|
| 15 |
Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375: 752-62.
DOI
ScienceOn
|
| 16 |
Harmon WG, Sleeper LA, Cuniberti L, Messere J, Colan SD, Orav EJ, et al. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 2009;104:281-6.
DOI
ScienceOn
|
| 17 |
Grenier MA, Fioravanti J, Truesdell SC, Mendelsohn AM, Vermilion RP, Lipshultz SE. Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a review. Prog Pediatr Cardiol 2000;12:91-111.
DOI
ScienceOn
|
| 18 |
Ostman-Smith I. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death. Fundam Clin Pharmacol 2010;24:637-52.
DOI
ScienceOn
|
| 19 |
Maskatia SA. Hypertrophic cardiomyopathy: infants, children, and adolescents. Congenit Heart Dis 2012;7:84-92.
DOI
ScienceOn
|
| 20 |
Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-85.
DOI
ScienceOn
|
| 21 |
Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186-95.
DOI
ScienceOn
|
| 22 |
Liu J, Sluijter JP, Goumans MJ, Smits AM, van der Spoel T, Nathoe H, et al. Cell therapy for myocardial regeneration. Curr Mol Med 2009;9:287-98.
DOI
ScienceOn
|
| 23 |
Vinge LE, Raake PW, Koch WJ. Gene therapy in heart failure. Circ Res 2008;102:1458-70.
DOI
ScienceOn
|
| 24 |
Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR- AMI trial. Eur Heart J 2006;27:2775-83.
DOI
ScienceOn
|
| 25 |
Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010;31:2715-26.
DOI
ScienceOn
|
| 26 |
Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 2009;54:250-4.
DOI
ScienceOn
|
| 27 |
Ostman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 2005;15:632-42.
DOI
ScienceOn
|
| 28 |
Maron BJ, Douglas PS, Graham TP, Nishimura RA, Thompson PD. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol 2005;45: 1322-6.
DOI
ScienceOn
|
| 29 |
Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-708.
DOI
ScienceOn
|
| 30 |
Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-28.
DOI
ScienceOn
|
| 31 |
Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 2004;51:1305-46.
DOI
ScienceOn
|
| 32 |
Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population- based study. Circulation 2005;112:1332-8.
DOI
ScienceOn
|
| 33 |
Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112: 855-61.
DOI
ScienceOn
|
| 34 |
Ho CY, Carlsen C, Thune JJ, Havndrup O, Bundgaard H, Farrohi F, et al. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2009;2:314-21.
|
| 35 |
McMahon CJ, Nagueh SF, Pignatelli RH, Denfield SW, Dreyer WJ, Price JF, et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004;109:1756-62.
DOI
ScienceOn
|
| 36 |
Menon SC, Ackerman MJ, Cetta F, O'Leary PW, Eidem BW. Significance of left atrial volume in patients <20 years of age with hypertrophic cardiomyopathy. Am J Cardiol 2008;102:1390-3.
DOI
ScienceOn
|
| 37 |
Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-23.
DOI
ScienceOn
|
| 38 |
Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006;114:1063-9.
DOI
ScienceOn
|
| 39 |
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007;50:1914-31.
DOI
ScienceOn
|
| 40 |
Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42:466-72.
DOI
ScienceOn
|
| 41 |
Taylor MR, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orphanet J Rare Dis 2006;1:27.
DOI
ScienceOn
|
| 42 |
Moak JP, Kaski JP. Hypertrophic cardiomyopathy in children. Heart 2012;98:1044-54.
DOI
|
| 43 |
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-2.
DOI
ScienceOn
|
| 44 |
Giles TD. New WHO/ISFC classification of cardiomyopathies: a task not completed. Circulation 1997;96:2081-2.
|
| 45 |
Thiene G, Corrado D, Basso C. Cardiomyopathies: is it time for a molecular classification? Eur Heart J 2004;25:1772-5.
DOI
ScienceOn
|
| 46 |
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16.
DOI
ScienceOn
|
| 47 |
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6.
|
webmaster
